KELSEY GROTHOUSE: Open Payments
NPI 1548802762 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 18 payments from 10 companies in 2025. Trend: 2023 $21 · 2024 $510 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $70 |
| Amgen Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: JARDIANCE, Ozempic, EVENITY, ZENPEP, BREZTRI, SHINGRIX, CAPLYTA, REXULTI.
Industry payments across KY — which companies pay providers there.
